Ovid Therapeutics Inc.OVIDNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-585.20%
↑ 80% vs avg
Percentile
P36
Within normal range
Streak
2 yr
Consecutive growthExpanding
Average
-2952.41%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -585.20% | +94.3% |
| 2024 | -10207.07% | +29.8% |
| 2023 | -14544.13% | -303.5% |
| 2022 | -3604.47% | -6135.6% |
| 2021 | 59.72% | +109.3% |
| 2020 | -642.96% | - |
| 2019 | 0.00% | - |
| 2018 | 0.00% | - |
| 2017 | 0.00% | - |
| 2016 | 0.00% | - |